help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Racine, M. S.
Right arrow Articles by Barkan, A. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Racine, M. S.
Right arrow Articles by Barkan, A. L.
The Journal of Clinical Endocrinology & Metabolism Vol. 89, No. 7 3326-3331
Copyright © 2004 by The Endocrine Society

Augmentation of Growth Hormone Secretion after Testosterone Treatment in Boys with Constitutional Delay of Growth and Adolescence: Evidence against an Increase in Hypothalamic Secretion of Growth Hormone-Releasing Hormone

Michael S. Racine, Kathy V. Symons, Carol M. Foster and Ariel L. Barkan

Department of Internal Medicine, Division of Endocrinology and Metabolism (M.S.R., A.L.B.), and Department of Pediatrics and Communicable Diseases, Division of Endocrinology (M.S.R., C.M.F.), University of Michigan Medical Center; and Department of Veterans Affairs Medical Center (K.V.S.), Ann Arbor, Michigan 48109

Address all correspondence and requests for reprints to: Ariel L. Barkan, M.D., Division of Endocrinology and Metabolism, 3920 Taubman Center, Box 0354, University of Michigan Medical Center, Ann Arbor, Michigan 48109. E-mail: abarkan{at}umich.edu.

The increase in pituitary GH secretion that occurs during mid-late puberty in boys follows an increase in circulating testosterone (T) concentration; the direct mechanism by which this occurs is unknown. We hypothesized that T increases GH secretion during puberty by augmenting hypothalamic output of GHRH. Using constant infusions of a GHRH antagonist, we tested this hypothesis in six early pubertal boys with constitutional delay of growth and adolescence who had a mean chronological age of 14.0 ± 0.3 yr and mean bone age of 11.4 ± 0.2 yr. Blood samples were obtained from subjects every 15 min for 24 h during the overnight infusion of normal saline (2000–0600 h) and again during the overnight infusion of GHRH antagonist (0.33 µg/kg/h) the following night. Subjects then received transdermal T (5-mg patch) for 12 h nightly and were studied again after 4 wk of treatment. Serum samples were assayed for GH and total ghrelin; the percent suppression of GH during GHRH antagonist infusion was calculated. Morning serum T rose from 0.44 ± 0.09 to 4.43 ± 0.74 µg/liter (P = 0.005). T treatment was associated with a 92.6% increase in mean nocturnal GH secretion area under the curve (830 ± 177 to 1599 ± 340 µg/24 h·liter). Infusion of GHRH-antagonist suppressed mean nocturnal GH area under the curve by 29.1% before T treatment (830 ± 177 to 621 ± 168 µg/24 h·liter), and by 29.4% after T treatment (1599 ± 340 to 1182 ± 249 µg/24 h·liter; P = 0.99). Somatotroph sensitivity to GHRH was tested with 0.1- and 1.0-µg/kg doses of GHRH-44 iv; GH response did not change with regard to T treatment. The mean 24-h concentration of total ghrelin was unchanged with regard to T treatment. In summary, nightly transdermal T administration in six boys with constitutional delay of growth and adolescence increased GH output almost 2-fold, whereas the degree of GH suppressibility by GHRH antagonist remained unchanged. We conclude that the T-associated augmentation of GH secretion during early puberty in boys is unlikely to involve an absolute increase in hypothalamic GHRH output.

This work was supported by USPHS Grants RO-1-DK-38449 (A.L.B.) and MO-1-RR00042 (University of Michigan General Clinical Research Center) and the Department of Veterans Affairs Medical Research Service (A.L.B.).

Abbreviations: AUC, Area under the curve; E2, estradiol; SRIH, somatostatin; T, testosterone.




This article has been cited by other articles:


Home page
J. Clin. Endocrinol. Metab.Home page
K. J. Mackelvie, G. S. Meneilly, D. Elahi, A. C. K. Wong, S. I. Barr, and J.-P. Chanoine
Regulation of Appetite in Lean and Obese Adolescents after Exercise: Role of Acylated and Desacyl Ghrelin
J. Clin. Endocrinol. Metab., February 1, 2007; 92(2): 648 - 654.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2004 by The Endocrine Society